Betsy A. Dusak

654 total citations
11 papers, 547 citations indexed

About

Betsy A. Dusak is a scholar working on Organic Chemistry, Molecular Biology and Nephrology. According to data from OpenAlex, Betsy A. Dusak has authored 11 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Organic Chemistry, 2 papers in Molecular Biology and 2 papers in Nephrology. Recurrent topics in Betsy A. Dusak's work include Synthesis and biological activity (3 papers), Platelet Disorders and Treatments (2 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). Betsy A. Dusak is often cited by papers focused on Synthesis and biological activity (3 papers), Platelet Disorders and Treatments (2 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). Betsy A. Dusak collaborates with scholars based in United States and Israel. Betsy A. Dusak's co-authors include Daniel L. Dexter, David P. Hesson, Jack B. Jiang, Ernest Hamel, Alan D. Schreiber, Douglas B. Cines, Michael T. Mennuti, Avner Yayon, Kristi Eidsvoog and William F. Herblin and has published in prestigious journals such as New England Journal of Medicine, Blood and The Journal of Immunology.

In The Last Decade

Betsy A. Dusak

10 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Betsy A. Dusak United States 7 244 234 95 54 47 11 547
David Y. Bouffard Canada 12 177 0.7× 437 1.9× 72 0.8× 72 1.3× 194 4.1× 17 743
Mary E. Scott United States 11 197 0.8× 186 0.8× 27 0.3× 15 0.3× 39 0.8× 13 453
Piedad Fernández‐Resa Spain 8 210 0.9× 254 1.1× 51 0.5× 189 3.5× 134 2.9× 17 525
RG Melton United Kingdom 12 134 0.5× 414 1.8× 30 0.3× 21 0.4× 190 4.0× 17 748
Katherine A. Rouleau United States 13 126 0.5× 221 0.9× 40 0.4× 27 0.5× 176 3.7× 17 548
Hieu Lam United States 6 99 0.4× 178 0.8× 47 0.5× 48 0.9× 225 4.8× 6 507
Glenys M. Otter United States 11 111 0.5× 211 0.9× 23 0.2× 21 0.4× 99 2.1× 24 369
Christina Cherian United States 15 110 0.5× 465 2.0× 70 0.7× 27 0.5× 80 1.7× 24 711
Christopher Weier United States 9 93 0.4× 257 1.1× 105 1.1× 73 1.4× 81 1.7× 13 530
Bo‐Tao Xin Netherlands 13 145 0.6× 395 1.7× 56 0.6× 29 0.5× 159 3.4× 20 492

Countries citing papers authored by Betsy A. Dusak

Since Specialization
Citations

This map shows the geographic impact of Betsy A. Dusak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Betsy A. Dusak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Betsy A. Dusak more than expected).

Fields of papers citing papers by Betsy A. Dusak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Betsy A. Dusak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Betsy A. Dusak. The network helps show where Betsy A. Dusak may publish in the future.

Co-authorship network of co-authors of Betsy A. Dusak

This figure shows the co-authorship network connecting the top 25 collaborators of Betsy A. Dusak. A scholar is included among the top collaborators of Betsy A. Dusak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Betsy A. Dusak. Betsy A. Dusak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Skowron, Gail, Daniel R. Kuritzkes, Melanie Thompson, et al.. (2002). Once‐Daily Quadruple‐Drug Therapy with Adefovir Dipivoxil, Lamivudine, Didanosine, and Efavirenz in Treatment‐Naive Human Immunodeficiency Virus Type 1–Infected Patients. The Journal of Infectious Diseases. 186(7). 1028–1033. 10 indexed citations
2.
Gross, Janet L., William F. Herblin, Betsy A. Dusak, et al.. (1993). Effects of Modulation of Basic Fibroblast Growth Factor on Tumor Growth In Vivo. JNCI Journal of the National Cancer Institute. 85(2). 121–131. 88 indexed citations
3.
Aungst, Bruce J., et al.. (1990). Effects of plasma protein binding displacement on the pharmacokinetics, tissue and tumor concentrations and efficacy of brequinar, a highly protein-bound antitumor agent.. Journal of Pharmacology and Experimental Therapeutics. 253(1). 230–236. 4 indexed citations
4.
Jiang, Jack B., et al.. (1990). Synthesis and biological evaluation of 2-styrylquinazolin-4(3H)-ones, a new class of antimitotic anticancer agents which inhibit tubulin polymerization. Journal of Medicinal Chemistry. 33(6). 1721–1728. 234 indexed citations
6.
Snider, Barry B., et al.. (1989). Cytotoxicity of synthetic racemic ptilocaulin: A novel cyclic guanidine. Investigational New Drugs. 7(2-3). 147–154. 9 indexed citations
7.
Dexter, Daniel L., David P. Hesson, Robert Ardecky, et al.. (1985). Activity of a novel 4-quinolinecarboxylic acid, NSC 368390 [6-fluoro-2-(2'-fluoro-1,1'-biphenyl-4-yl)-3-methyl-4-quinolinecarb oxylic acid sodium salt], against experimental tumors.. PubMed. 45(11 Pt 1). 5563–8. 80 indexed citations
8.
Cines, Douglas B., et al.. (1982). Immune Thrombocytopenic Purpura and Pregnancy. New England Journal of Medicine. 306(14). 826–831. 97 indexed citations
9.
Cines, Douglas B., et al.. (1982). Immune Thrombocytopenic Purpura and Pregnancy. Obstetrical & Gynecological Survey. 37(10). 616–618. 2 indexed citations
10.
Cines, Douglas B., et al.. (1982). Granulocyte-associated IgG in neutropenic disorders.. Blood. 59(1). 124–32. 21 indexed citations
11.
Guerry, DuPont, Betsy A. Dusak, Alan D. Schreiber, & Richard A. Cooper. (1978). B Lymphocyte Expression of a Recognition Locus for Human Monocytes and Macrophages. The Journal of Immunology. 121(6). 2446–2452. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026